ID

31488

Beschreibung

Study ID: 104619 Clinical Study ID: 63129 Study Title:A multinational, randomized, double-blind comparison of once daily subcutaneous fondaparinux sodium with placebo for the prevention of venous thromboembolic events in acutely ill medical patients (ARTEMIS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fondaparinux sodium Trade Name: Arixtra Study Indication: Thrombosis, Venous

Stichworte

  1. 28.08.18 28.08.18 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

28. August 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Subcutaneous fondaparinux sodium for prevention of venous thromboembolic events; Study ID: 104619

End of Treatment/End of Study

End of Treatment
Beschreibung

End of Treatment

Alias
UMLS CUI-1
C0087111
UMLS CUI-2
C0444930
Date of last administration
Beschreibung

Pharmaceutical Preparations; Date last dose

Datentyp

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1762893
Main reason for stopping treatment (tick one box only)
Beschreibung

Pharmaceutical preparations, end; Reason

Datentyp

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0444930
UMLS CUI [1,3]
C0566251
End of Study
Beschreibung

End of Study

Alias
UMLS CUI-1
C0008972
UMLS CUI-2
C0444930
Date of end of study
Beschreibung

Study end Date

Datentyp

date

Alias
UMLS CUI [1]
C2983670
Main reason for stopping study (tick one box only)
Beschreibung

Clinical Research, end; Reason

Datentyp

text

Alias
UMLS CUI [1,1]
C0008972
UMLS CUI [1,2]
C0444930
UMLS CUI [1,3]
C0566251
Was the study code broken at any time?
Beschreibung

Clinical Research; study code

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0008972
UMLS CUI [1,2]
C0805701

Ähnliche Modelle

End of Treatment/End of Study

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
End of Treatment
C0087111 (UMLS CUI-1)
C0444930 (UMLS CUI-2)
Pharmaceutical Preparations; Date last dose
Item
Date of last administration
date
C0013227 (UMLS CUI [1,1])
C1762893 (UMLS CUI [1,2])
Item
Main reason for stopping treatment (tick one box only)
text
C0013227 (UMLS CUI [1,1])
C0444930 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
Code List
Main reason for stopping treatment (tick one box only)
CL Item
Lack of efficacy (Lack of efficacy)
CL Item
Adverse event (Adverse event)
CL Item
Subject's request (Subject's request)
CL Item
Subject lost to follow-up (Subject lost to follow-up)
CL Item
Other reason (specify) (Other reason (specify))
CL Item
Poor compliance to protocol (Poor compliance to protocol)
CL Item
Completed study treatment period (Completed study treatment period)
Item Group
End of Study
C0008972 (UMLS CUI-1)
C0444930 (UMLS CUI-2)
Study end Date
Item
Date of end of study
date
C2983670 (UMLS CUI [1])
Item
Main reason for stopping study (tick one box only)
text
C0008972 (UMLS CUI [1,1])
C0444930 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
Code List
Main reason for stopping study (tick one box only)
CL Item
Lack of efficacy (Lack of efficacy)
CL Item
Adverse event (Adverse event)
CL Item
Subject's request (Subject's request)
CL Item
Subject lost to follow-up (Subject lost to follow-up)
CL Item
Other reason (specify) (Other reason (specify))
CL Item
Completed follow-up period (Completed follow-up period)
Clinical Research; study code
Item
Was the study code broken at any time?
boolean
C0008972 (UMLS CUI [1,1])
C0805701 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video